title: AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.
abstract: Identification of host factors that are needed for Zaire Ebolavirus (EBOV) entry provides insights into the mechanism(s) of filovirus uptake, and these factors may serve as potential antiviral targets. In order to identify novel host genes and pathways involved in EBOV entry, gene array findings in the National Cancer Institute's NCI-60 panel of human tumor cell lines were correlated with permissivity for EBOV glycoprotein (GP)-mediated entry. We found that the gene encoding the γ2 subunit of AMP-activated protein kinase (AMPK) strongly correlated with EBOV transduction in the tumor panel. The AMPK inhibitor compound C inhibited infectious EBOV replication in Vero cells and diminished EBOV GP-dependent, but not Lassa fever virus GPC-dependent, entry into a variety of cell lines in a dose-dependent manner. Compound C also prevented EBOV GP-mediated infection of primary human macrophages, a major target of filoviral replication in vivo. Consistent with a role for AMPK in filovirus entry, time-of-addition studies demonstrated that compound C abrogated infection when it was added at early time points but became progressively less effective when added later. Compound C prevented EBOV pseudovirion internalization at 37°C as cell-bound particles remained susceptible to trypsin digestion in the presence of the inhibitor but not in its absence. Mouse embryonic fibroblasts lacking the AMPKα1 and AMPKα2 catalytic subunits were significantly less permissive to EBOV GP-mediated infection than their wild-type counterparts, likely due to decreased macropinocytic uptake. In total, these findings implicate AMPK in macropinocytic events needed for EBOV GP-dependent entry and identify a novel cellular target for new filoviral antivirals.
authors.affiliation: Department of Microbiology, University of Iowa, Iowa City, IA, USA.
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Kondratowicz
authors.forename: Catherine L
authors.initials: CL
authors.lastname: Hunt
authors.forename: Robert A
authors.initials: RA
authors.lastname: Davey
authors.forename: Sara
authors.initials: S
authors.lastname: Cherry
authors.forename: Wendy J
authors.initials: WJ
authors.lastname: Maury
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000378:metabolism*; D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism; D002478:Cells, Cultured; D029043:Ebolavirus / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D008264:Macrophages / Q000821:virology; D010873:Pinocytosis; D011991:Receptors, Virus / Q000378:metabolism*; D014161:Transduction, Genetic; D053586:Virus Internalization
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D011991:Receptors, Virus; D055372:AMP-Activated Protein Kinases